What happened
IntelliProve, a Belgian healthtech startup, has closed a €2.7 million seed round, Tech.eu reported. Miles Ahead led the investment, joined by Wit-Gele Kruis, imec.istart and a number of business angels. The company builds software that lets ordinary cameras on phones, laptops and similar devices estimate health indicators without contact or any extra hardware.
A facial scan of 30 seconds returns six biomarkers, among them heart rate and its variability, breathing rate, resonant breathing, and both systolic and diastolic blood pressure. The approach uses remote photoplethysmography, reading small skin colour shifts from blood flow plus breathing motion. In-house tools VitalMesh, TripleGate and PulseShape handle skin tracking, signal quality checks and deep learning estimation of vitals.
Co-founder and co-CEO Joeri Tulkens said virtual care partners are embedding the product at the core of their services, described humanoid robots as the next step, and said the money is meant to make IntelliProve a health sensing layer usable with any camera across the world. Co-founder and CTO Tanguy Sanglet said moving onto new devices would not lower its bar for quality and accuracy.
Context
IntelliProve pitches its software as a response to ageing populations, staff shortages and rising care demand, since conventional monitoring tends to need dedicated equipment and trained staff. Its ISO 27001-certified technology already runs inside virtual care, health insurance and wellbeing platforms, and its models have been validated on more than six million data points, with the team contributing to peer-reviewed research.
ブリーフィング
1週間のテックニュースを1通のメールで。
読む価値のある記事を毎週お届けします。配信停止はいつでも可能です。
